MediPines Corporation
MediPines is a pioneering medical technology company headquartered in California, focused on transforming respiratory and cardiovascular assessment through non-invasive innovation. Their flagship product, the AGM100, is an FDA-cleared device that delivers real-time insights into a patient’s cardiorespiratory status—including oxygenation, ventilation, and gas exchange efficiency—without requiring invasive procedures. The company aims to empower healthcare professionals with an advanced, easy-to-use assessment system that supports faster, more precise diagnostic and treatment decisions, ultimately improving patient outcomes across emergency, acute, and chronic care environments. MediPines technology is in use across hospitals and outpatient clinics in North America, with expanding international interest.
Industries
Nr. of Employees
small (1-50)
MediPines Corporation
Yorba Linda, California, United States, North America
Products
Portable non-invasive pulmonary gas-exchange analyzer
A bedside breath-sampling diagnostic system that measures end-tidal oxygen and carbon dioxide, computes an arterial PO2 surrogate and an alveolar–arterial gradient surrogate, and reports a panel of respiratory metrics for rapid clinical triage and monitoring.
Portable non-invasive pulmonary gas-exchange analyzer
A bedside breath-sampling diagnostic system that measures end-tidal oxygen and carbon dioxide, computes an arterial PO2 surrogate and an alveolar–arterial gradient surrogate, and reports a panel of respiratory metrics for rapid clinical triage and monitoring.
Services
Clinical research collaboration
Partnerships with hospitals and academic researchers to run studies, generate peer-reviewed evidence, and evaluate clinical utility of non-invasive gas-exchange measurement.
Device training and onboarding
Short-form training modules and educational resources to teach clinicians and staff how to perform breath-based tests and interpret derived gas-exchange metrics.
Customer support and maintenance
Post-sale technical support, warranty service, and guidance on routine maintenance including sensor replacement and battery servicing.
Distribution and reseller partnership management
Selection and management of regional distributors and resellers to enable local market access, logistics, and service delivery.
Reimbursement and coding support
Guidance and documentation to support clinicians and facilities in coding and billing for non-invasive cardiorespiratory assessment procedures.
Clinical research collaboration
Partnerships with hospitals and academic researchers to run studies, generate peer-reviewed evidence, and evaluate clinical utility of non-invasive gas-exchange measurement.
Device training and onboarding
Short-form training modules and educational resources to teach clinicians and staff how to perform breath-based tests and interpret derived gas-exchange metrics.
Customer support and maintenance
Post-sale technical support, warranty service, and guidance on routine maintenance including sensor replacement and battery servicing.
Distribution and reseller partnership management
Selection and management of regional distributors and resellers to enable local market access, logistics, and service delivery.
Reimbursement and coding support
Guidance and documentation to support clinicians and facilities in coding and billing for non-invasive cardiorespiratory assessment procedures.
Expertise Areas
- Point-of-care pulmonary diagnostics and monitoring
- Pulmonary gas-exchange physiology and non-invasive measurement
- Clinical validation and academic research partnerships
- Regulatory compliance and medical device quality systems (FDA, ISO 13485 / MDSAP)
Key Technologies
- Non-invasive exhaled gas analysis
- End-tidal O2 and CO2 measurement
- Algorithmic arterial PO2 estimation from exhaled gases
- Alveolar–arterial gradient surrogate (oxygen deficit) measurement